Trial Profile

A Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 04 Nov 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Imiquimod (Primary)
Indications Genital warts
Focus Registrational; Therapeutic Use
Sponsors Graceway Pharmaceuticals

Most Recent Events

19 Jul 2011 Company added in the association field, additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
10 Jul 2010 Results from a pooled analysis of phase III trials evaluating the use of imiquimod for the treatment of genital warts have been presented at the Human Papillomavirus Conference, Montreal, 3-8 Jul 2010, according to a Graceway media release.
29 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com